Literature DB >> 28905089

[Radiochemotherapy improves failure-free survival in stage III endometrial cancer : Final results of the PORTEC-3 trial].

David Krug1, Nathalie Arians2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28905089     DOI： 10.1007/s00066-017-1209-7

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  5 in total

1.  Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial.

Authors:  Stephanie M de Boer; Melanie E Powell; Linda Mileshkin; Dionyssios Katsaros; Paul Bessette; Christine Haie-Meder; Petronella B Ottevanger; Jonathan A Ledermann; Pearly Khaw; Alessandro Colombo; Anthony Fyles; Marie-Helene Baron; Henry C Kitchener; Hans W Nijman; Roy F Kruitwagen; Remi A Nout; Karen W Verhoeven-Adema; Vincent T Smit; Hein Putter; Carien L Creutzberg
Journal:  Lancet Oncol       Date:  2016-07-07       Impact factor: 41.316

2.  Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.

Authors:  Marcus E Randall; Virginia L Filiaci; Hyman Muss; Nick M Spirtos; Robert S Mannel; Jeffrey Fowler; J Tate Thigpen; Jo Ann Benda
Journal:  J Clin Oncol       Date:  2005-12-05       Impact factor: 44.544

3.  Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies.

Authors:  Thomas Hogberg; Mauro Signorelli; Carlos Freire de Oliveira; Roldano Fossati; Andrea Alberto Lissoni; Bengt Sorbe; Håkan Andersson; Seija Grenman; Caroline Lundgren; Per Rosenberg; Karin Boman; Bengt Tholander; Giovanni Scambia; Nicholas Reed; Gennaro Cormio; Germana Tognon; Jackie Clarke; Tomasz Sawicki; Paolo Zola; Gunnar Kristensen
Journal:  Eur J Cancer       Date:  2010-07-07       Impact factor: 9.162

Review 4.  Adjuvant chemotherapy for advanced endometrial cancer.

Authors:  Khadra Galaal; Mansour Al Moundhri; Andrew Bryant; Alberto D Lopes; Theresa A Lawrie
Journal:  Cochrane Database Syst Rev       Date:  2014-05-15

5.  Integrated genomic characterization of endometrial carcinoma.

Authors:  Cyriac Kandoth; Nikolaus Schultz; Andrew D Cherniack; Rehan Akbani; Yuexin Liu; Hui Shen; A Gordon Robertson; Itai Pashtan; Ronglai Shen; Christopher C Benz; Christina Yau; Peter W Laird; Li Ding; Wei Zhang; Gordon B Mills; Raju Kucherlapati; Elaine R Mardis; Douglas A Levine
Journal:  Nature       Date:  2013-05-02       Impact factor: 49.962
  5 in total
  1 in total

Review 1.  Evolution of adjuvant treatment in endometrial cancer-no evidence and new questions?

Authors:  S Marnitz; C Köhler; N Gharbi; S Kunze; K Jablonska; J Herter
Journal:  Strahlenther Onkol       Date:  2018-08-15       Impact factor: 3.621
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.